“Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer.” By F.E. Vera-Badillo, R. Shapiro, A. Ocana, E. Amir and I.F. Tannock, Annals of oncology (PDF)
Of the 164 studies included in a literature review of Phase III randomized, clinical trials (RCTs) from 1995 to 2011, . . . → Read More: Bias in reporting of end points of efficacy and toxicity